Conceivably, this may indicate the way BPC 157, given peripherally, may specifically interfere with the ketamine-induced effects, likely on the specific brain targets, regardless of the possible limitation of results only reflecting mRNA levels, which may not correlate with protein levels [38]
BPC-157 works locally it modulates your nitric oxide system, ramps up growth factors (VEGF, EGF, TGF-beta), and gets repair cells moving to the injury via the FAK-paxillin pathway
What Is PDA (BPC-157-Arginine)
NMN (nicotinamide mononucleotide) is a well-known NAD precursor studied for its role in mitochondrial function, cellular energy production, and aging-related processes
This duo promotes protein synthesis, lean mass accrual, and recovery in the preconception period which can optimize BMR and fat loss
A formal Phase I human safety trial was started in 2015, but the sponsor In the world of drug development, this is a massive red flag that strongly suggests a problem was found